Back
Black Diamond Therapeutics Vs. Ligand Pharmaceuticals Industry Stock Comparison
Sell
40
BDTX
Black Diamond Therapeutics
Last Price:
2.55
Seasonality Move:
28.2%
Buy
62
LGND
Ligand Pharmaceuticals
Last Price:
119.43
Seasonality Move:
16.9%
Sell
40
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy, Sell or Hold?
- The current Black Diamond Therapeutics [BDTX] share price is $2.54. The Score for BDTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- BDTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $119.19. The Score for LGND is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BDTX Stock Price Chart
What is Black Diamond Therapeutics's stock price today?
-
The Black Diamond Therapeutics share price today is $2.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight buying pressure.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $119.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 34.16 | Sell |
| Chaikin Money Flow: | 181044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.65 - 3.23) | Sell |
| Bollinger Bands (100): | (3.33 - 5.87) | Sell |
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.09 | Buy |
| Relative Strength Index (14 RSI): | 57.87 | Buy |
| Chaikin Money Flow: | 53261 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.14 - 119.94) | Buy |
| Bollinger Bands (100): | (97.23 - 112.11) | Buy |
BDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.63 | Sell |
| 20-day SMA: | 2.9 | Sell |
| 50-day SMA: | 3.54 | Sell |
| 200-day SMA: | 4.85 | Sell |
| 8-day EMA: | 2.64 | Sell |
| 20-day EMA: | 2.9 | Sell |
| 50-day EMA: | 3.52 | Sell |
| 200-day EMA: | 4.29 | Sell |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115 | Buy |
| 20-day SMA: | 115.4 | Buy |
| 50-day SMA: | 108.27 | Buy |
| 200-day SMA: | 91.22 | Buy |
| 8-day EMA: | 115.73 | Buy |
| 20-day EMA: | 114.41 | Buy |
| 50-day EMA: | 109.88 | Buy |
| 200-day EMA: | 94.65 | Buy |
Black Diamond Therapeutics Earnings Growth & BDTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.38 per share.
Black Diamond Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ligand Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||